Related Experiment Video
Updated: Aug 23, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Improving cancer therapy through p53 management
1Department of Pharmaceutics, School of Pharmacy, Hadassah Medical School, The Hebrew University, Jerusalem, Israel.
Abstract:
The tumor suppressor p53 normally acts to appropriately coordinate cellular responses to stress stimuli. When p53 activity is disabled, the onset of malignancy is a potential consequence. Engendering wild type p53 activities in cells that lack these functions is an approach that is currently being explored for cancer therapy. Eliciting elevated levels of active p53, imparting p53 activities through gene therapy, compelling mutant p53 to perform normal functions, manipulating p53 regulators, and activating p53 effectors are all approaches that are currently being developed. In this review we will provide a synopsis of the most promising 'p53-based' strategies for fighting cancer, both those under clinical trial and recent innovative concepts.
Insights
Restoring the tumor suppressor p53
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The tumor suppressor p53 is crucial for cellular responses to stress.
- Loss of p53 function can lead to cancer development.
- Restoring p53 activity is a therapeutic strategy for malignancy.
Purpose of the Study:
- To review promising p53-based cancer therapies.
- To discuss strategies currently in clinical trials.
- To explore innovative p53-targeting concepts.
Main Methods:
- Review of clinical trials involving p53-based therapies.
- Analysis of novel therapeutic concepts targeting p53.
- Synopsis of methods to restore or mimic p53 functions.
Main Results:
- Several p53-based strategies are under clinical investigation.
- Innovative approaches aim to re-engage p53 in cancer cells.
- Gene therapy and p53 reactivation show therapeutic potential.
Conclusions:
- p53-based strategies represent a promising avenue for cancer treatment.
- Restoring wild-type p53 function is a key therapeutic goal.
- Ongoing research continues to develop novel p53-targeting therapies.
Related Concept Videos
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
DNA Damage Can Stall the Cell Cycle

